Evidence map›Paper›PMID 37531659›Full record

ArticleACS chemical biology2023

Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages.

Jonah E Zarrow, Abdul-Musawwir Alli-Oluwafuyi, Cristina M Youwakim, Kwangho Kim, Andrew N Jenkins, Isabelle C Suero, Margaret R Jones, Zahra Mashhadi, Ken Mackie, Alex G Waterson and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Nanoengineered GATA3International journal of nanomedicine · 2026
    Article
  6. Efferocytosis in liver disease.JHEP reports : innovation in hepatology · 2024
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jonah E ZarrowDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0003-2536-2297
Abdul-Musawwir Alli-OluwafuyiDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
Cristina M YouwakimDepartment of Medicine, Division of Cardiology, Vanderbilt University Medical Center. Nashville, Tennessee 37232, United States.
Kwangho KimDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
Andrew N JenkinsDepartment of Cell Biology and Physiology, Brigham Young University. Provo, Utah 84602, United States.
Isabelle C SueroDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
Margaret R JonesDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.ORCID 0000-0002-0540-6312
Zahra MashhadiDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
Ken MackieGill Center and Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana 47405, United States.ORCID 0000-0001-8501-6199
Alex G WatersonDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
Amanda C DoranDepartment of Medicine, Division of Cardiology, Vanderbilt University Medical Center. Nashville, Tennessee 37232, United States.
Gary A SulikowskiDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0002-1067-0767
Sean S DaviesDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0001-9879-8062
Vanderbilt University · USVanderbilt University Medical Center · USBrigham Young University · USIndiana University Bloomington · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KON, VALENTINA · 2014 to 2025
$24.7M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
An automated portable system for detecting and treating opioid induced respiratory depressionU01DA056242 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI GUO, FENG, MACKIE, KENNETH · 2022 to 2024
$3.8M
Critical Mediators of Inflammation Resolution and Immune Memory in AtherosclerosisR01HL159487 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DORAN, AMANDA C · 2021 to 2025
$3.2M
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and DependenceR01DA047858 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI HOHMANN, ANDREA GRACE, MACKIE, KENNETH · 2019 to 2023
$2.6M
Fluorescent and Luminescent Kinetic Imaging Plate ReaderS10OD021734 · OD · VANDERBILT UNIVERSITY · PI LINDSLEY, CRAIG · 2016 to 2016
$671k
NCI NIH HHS P30 CA068485NHLBI NIH HHS P01 HL116263NHLBI NIH HHS R01 HL159487NIDA NIH HHS R01 DA047858NIDA NIH HHS U01 DA056242NIGMS NIH HHS T32 GM065086NIH HHS S10 OD021734
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesPhospholipase DAnimalsBrainHumansMacrophagesMicePhosphatidylethanolaminesNapepld protein, mousePhosphatidylethanolaminesPhospholipase D

Identifiers

PMID37531659
PMCPMC10443532
OpenAlexW4385487239

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.